Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Wild

Showing results (51-60 of 104) with videos related to

Pageof 11
Sort By:
Environmental and Molecular Mutagenesis|July 16, 2008
Influence of DNA repair gene polymorphisms on the initial repair of MMS-induced DNA damage in human lymphocytes as measured by the alkaline comet assayCharlotta Ryk, Michael N Routledge, James M Allan, et al.
Proteomics|April 5, 2011
Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenolAndré Nogueira da Costa, Renée S Mijal, Jeffrey N Keen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Genetic variation and cancer: improving the environment for publication of association studiesTimothy R Rebbeck, María Elena Martínez, Thomas A Sellers, et al.
The British Journal of Nutrition|November 28, 2018
Trends of serum phospholipid fatty acids over time in rural Uganda: evidence of nutritional transition?Véronique Chajès, Lorna J Gibson, Carine Biessy, et al.
British Journal of Haematology|February 19, 2002
Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalitiesPierre Lebailly, Eleanor V Willett, Anthony V Moorman, et al.
Environmental Health Perspectives|January 17, 2008
Urinary deoxynivalenol is correlated with cereal intake in individuals from the United kingdomPaul C Turner, Joseph A Rothwell, Kay L M White, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 12, 2010
Assessment of deoxynivalenol metabolite profiles in UK adultsPaul C Turner, Richard P Hopton, Kay L M White, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Risk factors, DNA damage, and disease progression in Barrett's esophagusJoanna R Olliver, Laura J Hardie, Yunyun Gong, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|June 24, 2008
Deoxynivalenol: rationale for development and application of a urinary biomarkerPaul C Turner, Victoria J Burley, Joseph A Rothwell, et al.
Cancer Letters|December 25, 2004
p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterationsLaura J Hardie, S Jane Darnton, Yvonne L Wallis, et al.
Pageof 11

Showing results (51-60 of 104) with videos related to

Sort By:
Pageof 11
Environmental and Molecular Mutagenesis|July 16, 2008
Influence of DNA repair gene polymorphisms on the initial repair of MMS-induced DNA damage in human lymphocytes as measured by the alkaline comet assayCharlotta Ryk, Michael N Routledge, James M Allan, et al.
Proteomics|April 5, 2011
Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenolAndré Nogueira da Costa, Renée S Mijal, Jeffrey N Keen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 16, 2004
Genetic variation and cancer: improving the environment for publication of association studiesTimothy R Rebbeck, María Elena Martínez, Thomas A Sellers, et al.
The British Journal of Nutrition|November 28, 2018
Trends of serum phospholipid fatty acids over time in rural Uganda: evidence of nutritional transition?Véronique Chajès, Lorna J Gibson, Carine Biessy, et al.
British Journal of Haematology|February 19, 2002
Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalitiesPierre Lebailly, Eleanor V Willett, Anthony V Moorman, et al.
Environmental Health Perspectives|January 17, 2008
Urinary deoxynivalenol is correlated with cereal intake in individuals from the United kingdomPaul C Turner, Joseph A Rothwell, Kay L M White, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 12, 2010
Assessment of deoxynivalenol metabolite profiles in UK adultsPaul C Turner, Richard P Hopton, Kay L M White, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Risk factors, DNA damage, and disease progression in Barrett's esophagusJoanna R Olliver, Laura J Hardie, Yunyun Gong, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|June 24, 2008
Deoxynivalenol: rationale for development and application of a urinary biomarkerPaul C Turner, Victoria J Burley, Joseph A Rothwell, et al.
Cancer Letters|December 25, 2004
p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterationsLaura J Hardie, S Jane Darnton, Yvonne L Wallis, et al.
Pageof 11